THIS PROJECT IS
NOT APPROVED FOR THE FOLLOWING REASONS: 1) OMB IS NOT CONVINCED
THAT THE USE OF A CONVENIENCE SAMPLE WILL PROVIDE GENERALIZABLE
RESULTS. 2) THE SURVEY INSTRUMENT IS TOO LENGTHY, COMPLEX AND
REDUNDANT, PARTICULARLY FOR USE IN A NON-HOUSEHOLD SETTING, AND 3)
THE PROPOSED RESEARCH DESIGN CONFUSES ISSUES OF "UNDERSTANDABILITY"
AND "SIMILARITY" OF TERMS. RESULTS OF THIS SURVEY, IF APPROVED,
WOULD NOT BE ACCEPTED BY INDUSTRY AND WOULD PERPETUATE DISAGREEMENT
ON THE ISSUE OF OTC LABELING. FDA IS ENCOURAGED TO SUBMIT AN
IMPROVED RESEARCH DESIGN TO OMB FOR RECONSIDERATION.
Inventory as of this Action
Requested
Previously Approved
01/12/1981
0
0
0
0
0
0
0
0
0
THE DATA COLLECTION AND ANALYSIS ARE
INTENDED TO ASSIST FDA IN THE PREPARATION OF TRUTHFUL,
NONMISLEADING, MEDICALLY ACCURATE AND UNDER STANDABLE TERMS FOR USE
IN WRITING LABELING FOR OTC DRUG PRODUCTS.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.